Banks Healthcare Sector

Syndax Pharmaceuticals

Market Cap: US$943.1m

A commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.

Evolent Health

Market Cap: US$939.6m

Through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States.

InMode

Market Cap: US$931.1m

Designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally.

Nurix Therapeutics

Market Cap: US$927.0m

A clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases.

Niagen Bioscience

Market Cap: US$924.7m

Operates as a bioscience company engages in developing healthy aging products.

agilon health

Market Cap: US$906.6m

Provides healthcare services for seniors through primary care physicians in the communities of the United States.

Pharvaris

Market Cap: US$905.7m

A late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases.

Avadel Pharmaceuticals

Market Cap: US$900.6m

Operates as a biopharmaceutical company in the United States.

Extendicare

Market Cap: CA$1.2b

Through its subsidiaries, provides care and services for seniors in Canada.

Ardelyx

Market Cap: US$882.9m

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.

HealthStream

Market Cap: US$865.7m

Provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States.

Nanosonics

Market Cap: AU$1.3b

Operates as an infection prevention company globally.

Zymeworks

Market Cap: US$850.1m

A clinical-stage biotechnology company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer, and autoimmune and inflammatory diseases (AIID).

Beta Bionics

Market Cap: US$843.3m

A commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes.

Praxis Precision Medicines

Market Cap: US$842.7m

A clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance.

CorMedix

Market Cap: US$839.7m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

Nuvation Bio

Market Cap: US$833.6m

A clinical-stage biopharmaceutical company, focuses on developing therapeutic candidates for oncology.

STAAR Surgical

Market Cap: US$825.3m

Designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye.

LENZ Therapeutics

Market Cap: US$821.6m

Operates as a biopharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States.

uniQure

Market Cap: US$819.0m

Develops treatments for patients suffering from rare and other devastating diseases in the United States.

Intellia Therapeutics

Market Cap: US$794.5m

A clinical-stage gene editing company, focuses on the development of curative genome editing treatments.

SI-BONE

Market Cap: US$787.9m

A medical device company, focuses on solving musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally.

Immunome

Market Cap: US$784.9m

A clinical-stage biotechnology company, develops targeted cancer therapies.

Gyre Therapeutics

Market Cap: US$777.8m

A pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis.

ArriVent BioPharma

Market Cap: US$777.3m

A clinical-stage biopharmaceutical company, engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers.

IRADIMED

Market Cap: US$772.8m

Develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally.

GH Research

Market Cap: US$771.0m

Together with its subsidiary, a clinical-stage biopharmaceutical company, engages in developing treatments for depression in the United States.

AMN Healthcare Services

Market Cap: US$767.6m

Provides technology-enabled healthcare workforce solutions and staffing services to acute and sub-acute care hospitals, and other healthcare facilities in the United States.

Trulieve Cannabis

Market Cap: CA$1.0b

Operates as a cannabis retailer.

Nutex Health

Market Cap: US$753.4m

Operates as a physician-led, healthcare services, and operations company in the United States.

Cronos Group

Market Cap: CA$1.0b

A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.

Replimune Group

Market Cap: US$747.0m

A clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer.

WELL Health Technologies

Market Cap: CA$1.0b

Operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally.

Veradigm

Market Cap: US$730.3m

A healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally.

Vir Biotechnology

Market Cap: US$729.9m

A clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally.

AbCellera Biologics

Market Cap: US$722.3m

Engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States.